In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Remedy Pharmaceuticals Inc.

www.remedypharmaceuticals.com

Latest From Remedy Pharmaceuticals Inc.

TMS Stroke Deal Suggests No Big Buy From Biogen Yet

The investment community has been willing Biogen to make a big deal for some time now but a modest pact inked with Japan's TMS for its Phase II acute ischemic stroke drug suggests that management will continue to favor picking up promising compounds rather than diving into major M&A.

Neurology Deals

Biogen's Spinraza Sales Plateau; The Challenge Is Keeping Up With The Successful Launch

Sales of Biogen's blockbuster rare disease drug moderated in the first quarter as the company worked through the bolus of urgent infant and pediatric patients awaiting treatment in the US.

Sales & Earnings Neurology

Natalizumab Fails In Stroke But A Phase III Study Of BIIB093 Beckons

Biogen's MS therapy natalizumab may have been a disappointment in ischemic stroke, but the neuroscience-focused company is aiming to soon move another potential stroke therapy into late-stage clinical studies.

Clinical Trials Research & Development

A Deal For Biogen, But Not The One Investors Are Waiting For

The firm announced a small deal with Karyopharm for a preclinical asset with potential in ALS, but large deals are also being considered, management told the fourth quarter earnings call.

M & A Deals
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Remedy Pharmaceuticals Inc.
  • Senior Management
  • Sven Jacobson, CEO
    Richard Steinhart, CFO
    Thomas W MacAllister, PhD, VP, R&D
  • Contact Info
  • Remedy Pharmaceuticals Inc.
    Phone: (212) 586-2226
    233 Broadway
    17th Fl.
    New York, NY 10279
    USA
UsernamePublicRestriction

Register